Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL855690 | 0.83 | CES1 (0.63) | CES1CES2AKR1B1PAMMEN1 | |
| SCHEMBL20917148 | 0.82 | CES1 (0.53) | CES1CES2AKR1B1PAMMEN1 | |
| SCHEMBL11730655 | 0.81 | CES1 (0.52) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL7558091 | 0.81 | CES1 (0.61) | CES1CES2AKR1B1PAMMEN1 | |
| SCHEMBL28410796 | 0.80 | ALDH1A1 (0.57) | CES1MEN1KMT2AHDAC8HDAC6 | |
| SCHEMBL12902954 | 0.79 | CES1 (0.59) | CES1CES2AKR1B1PAMMEN1 | |
| SCHEMBL16405134 | 0.79 | CES1 (0.70) | CES1CES2AKR1B1PAMMEN1 | |
| SCHEMBL5647919 | 0.79 | SLC6A2 (0.53) | CES1CES2AKR1B1PAMMEN1 | |
| SCHEMBL27781004 | 0.79 | CES1 (0.53) | CES1CES2AKR1B1PAMMEN1 | |
| SCHEMBL1195864 | 0.78 | CES1 (0.57) | CES1CES2AKR1B1PAMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111164194-B | Structured unit dose cleaning products | 路博润先进材料公司 | 2022-10-25 | — | — | CN | disclosed |
| EP-4059573-A1 | SOLUBILISING AGENTS AND COMPOSITIONS COMPRISING SAME | B&Sens (FR) | 2022-09-21 | — | — | EP | disclosed |
| CN-109952116-B | Solid non-aqueous gel air odorants | 陶氏环球技术有限责任公司 | 2021-02-09 | — | — | CN | disclosed |
| CN-112218612-A | Hair modification compositions and methods | 路博润先进材料公司 | 2021-01-12 | — | — | CN | disclosed |
| EP-3078365-B1 | SOLUBILIZING AGENTS AND AQUEOUS COMPOSITIONS COMPRISING THEM | DAITO KASEI IND FRANCE (FR) | 2020-03-04 | — | — | EP | disclosed |
| EP-3015100-B1 | COSMETIC | KAO CORP (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-9757331-B2 | Stabilized active compound | PRAYON SA (BE) | 2017-09-12 | — | — | US | disclosed |
| EP-3145591-A1 | COSMETIC COMPOSITION | L'OREAL (FR) | 2017-03-29 | — | — | EP | disclosed |
| US-20170042775-A1 | COSMETIC COMPOSITION | L'OREAL (FR) | 2017-02-16 | — | — | US | disclosed |
| US-20160367454-A1 | COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2016-12-22 | — | — | US | disclosed |
| EP-1797054-A2 | ARYL-AMINO SUBSTITUTED PYRROLOPYRIMIDINE MULTI-KINASE INHIBITING COMPOUNDS | OSI Pharmaceuticals, Inc. (US) | 2007-06-20 | — | — | EP | disclosed |
| US-20060211678-A1 | Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds | OSI PHARMACEUTICALS, INC. | 2006-09-21 | — | — | US | disclosed |
| WO-2006084586-A1 | DISPERSION OBTAINABLE WITHOUT SOLVENTS AND CONTAINING A 1:1 OR 2:1 CYCLODEXTRIN-ODORIFEROUS SUBSTANCE COMPLEX | WACKER CHEMIE AG (DE) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006017443-A2 | ARYL-AMINO SUBSTITUTED PYRROLOPYRIMIDINE MULTI-KINASE INHIBITING COMPOUNDS | OSI PHARMACEUTICALS, INC. (US) | 2006-02-16 | — | — | WO | disclosed |
| US-20060008533-A1 | Adsorbates containing active substances | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-12 | — | — | US | disclosed |
| US-20050119150-A1 | Portioned detergent composition | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2005-06-02 | — | — | US | disclosed |
| US-20040259751-A1 | Dosed washing and cleaning agent composition | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-12-23 | — | — | US | disclosed |
| US-6432391-B1 | FOR APPLICATION TO COSMETIC SUBSTRATES CHOSEN FROM HUMAN SKIN, KERATINOUS SUBSTANCES, SCALPS, AND LIPS, AND WHICH COMPRISES A LIQUID FATTY PHASE GELLED BY A FATTY POLYAMIDE | L'ORéAL S.A. (FR) | 2002-08-13 | — | — | US | disclosed |
| US-20020044918-A1 | Transparent scented solid cosmetic composition | L'OREAL S.A. (FR) | 2002-04-18 | — | — | US | disclosed |
| US-4012392-A | ANALGESICS, MORPHINE ANTAGONISTS | ACF CHEMIEFARMA N.V. (NL) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060008533-A1 | Adsorbates containing active substances | LIPA, HDLBP, APOB | CES1 536/4885CES2 1097/4885AKR1B1 243/4885 |
| US-20060211678-A1 | Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds | BMX, ERBB2, FRK | CES1 4526/4885CES2 4814/4885AKR1B1 2601/4885 |
| US-20170042775-A1 | COSMETIC COMPOSITION | CUTA, DSG1, H1-0 | CES1 2827/4885CES2 3110/4885AKR1B1 2957/4885 |
| US-20020044918-A1 | Transparent scented solid cosmetic composition | CUTA, FASN, ACADM | CES1 536/4885CES2 242/4885AKR1B1 3220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.